Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Genius Finalizes Closing and Issues Consideration Shares for the Acquisition of Reiva Assets

MONTREAL, QUEBEC--(Marketwired - Jun 16, 2015) - Genius Properties Ltd. ("Genius" or the "Corporation") (CSE:GNI) announces that further to its news release of May 26, 2015, it has finalized the closing of the arms-length acquisition of all the assets of Reïva by issuing to the seller today an aggregate thirty million (30,000,000) new common shares (the "Consideration Shares") from the Corporation's share capital. The Consideration Shares are subject to a thirty-six (36) month escrow, in accordance with CSE policies and applicable securities regulation.

Genius has also issued today finder's fees in connection with the transaction totaling 1,400,000 shares to a non-arm's length party who was specifically commissioned and without whom the transaction would otherwise not have been entered into. The Shares issued as finder's fees will be subject to a thirty-six (36) month escrow, in accordance with CSE policies and applicable securities regulation.

About Reïva

Reïva has developed a range of world class exclusive products, a "next generation" of natural and functional beverages and line extensions. Its founder's primary objective is to offer a healthier lifestyle to consumers. When Denis Richard started developing world class exclusive formulas, he addressed the problems at their source, in collaboration with universities and independent laboratories. The Reïva team is committed to producing safe and efficient products designed to fill the void in the industry by offering consumers products focused on health and wellness. The team's devotion is supported by several pending patent applications.

Reïva is developing these products under the supervision of M. Guy Chamberland, M. Sc., Ph.D., Master herbalist and specialist in drug development. He has spent more than 15 years in the pharmaceutical industry and has commercialized new products, from their discovery to human clinical trials and to the market. He holds a master of science (M. Sc.) and a doctor of philosophy (Ph.D.) in biomedical sciences (in the field of toxicology). He has developed expertise in drugs safety and regulatory affairs while working in the pharmaceutical and biotech industry.

Reïva Global Corp. aims markets with high sales volumes, such as:

  • The energy drinks market (37 billion dollars in 2014);

  • The sports nutrition supplements market (4.2 billion dollars in 2014);

  • The energy bars market (more than one billion dollars in 2014);

  • The children's healthy snacks market.

The "REÏVA" products include the following features:

  • They have a first choice antioxidant power;

  • They greatly improve sports performances;

  • They improve blood circulation;

  • They improve control on good and bad cholesterol;

  • They have recognized cardiovascular features;

  • They are high quality dietary supplements;

  • They help the body metabolize carbohydrates, fats and proteins;

  • They help maintain good muscular functions;

  • They help the regeneration of red blood cells;

  • They reinforce the immune system;

  • And much more.